Vimarsana
Biggest News Aggregation in the World

Generic Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generic Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generic Drug Today - Breaking & Trending Today

CSPAN2 After Words Sally Hubbard Monopolies Suck July 11, 2024 - Vimarsana News

CSPAN2 After Words Sally Hubbard Monopolies Suck July 11, 2024

The Incoming Biden Administration i thought we should begin with kind of the big picture that you lay out in the book when people hear the title they might say of course. I think many people may not fully understand. Taking the time to talk about this book and thank you to cspan for having me here to talk about it as well. That isnt a surprise for anyone but what has been happening over the last several decades is our economy has been highly concentrated and theres been consolidation on an ongoing basis in every sector of the economy so we hear a lot about but not only are we talking about foo...

CSPAN2 After Words Sally Hubbard Monopolies Suck July 11, 2024 - Vimarsana News

CSPAN2 After Words Sally Hubbard Monopolies Suck July 11, 2024

Sally hubbard thank you for coming on to discuss monopolies suck it is timely because the issue you write about in the book with us economy and the impact on workers and citizens is a hot topic at the moment with policymaking right now and it could play a big and the Incoming Biden Administration so i thought we should look at the big picture you lay out in the book when people hear the title no one likes monopolies are dealing with monopolies but really this book is about a bigger issue that the economy people may not fully understand. s so can you set the scene and describe what you see happ...

BLOOMBERG Bloomberg Markets Americas July 11, 2024 - Vimarsana News

BLOOMBERG Bloomberg Markets Americas July 11, 2024

Happening here. We continue with this outperformance from the small caps. We continue with this rotation. Abigail we do, and today is relatively subtle. The outperformance came from energy and financials, which at the end of the day finished higher. Today we are once again seeing movement into the cyclical sectors even though the s p 500 on the surface is basically flat. The nasdaq 100 is lower. You were mentioning the small caps. The russell out another alltime high on the day. You again have investors moving to small caps, value, the cyclical sectors. Theres the financials. Industrials, ener...

CSPAN2 After Words Sally Hubbard Monopolies Suck July 11, 2024 - Vimarsana News

CSPAN2 After Words Sally Hubbard Monopolies Suck July 11, 2024

You for coming on to discuss monopolies suck. Its a very timely book because the issues you write about in the book, the power of dominant companies in the u. S. Economy and the impact on workers and consumers and citizens is really a very hot topic in economics and policy making right now. And we will see but could play a big role in the incoming Biden Administration. So i thought we should begin with sort of the big picture about, that you lay out in the book. I think when people hear the title they might say of course, no one likes monopolies, no one likes dealing with monopolies. The relig...

CSPAN2 National Book Festival - Katherine Eban Bottle Of Lies July 11, 2024 - Vimarsana News

CSPAN2 National Book Festival - Katherine Eban Bottle Of Lies July 11, 2024

Inside story of the generic drug boom and im talking t you today from massachutts. Im actually usuly based in brooklyn, new york, but were hunkering down in cape cod this summer. My book is a true crime expose of the generic drug industry an takes the readers deep into the distantanufacturing plants in india and china that make most of americas low cost medicines. Heavily reported over the course of 10 years, the book follows several key characters, an industry whistle blower, a fda investigator as they begin to uncover widespread fraud in these manufacturing plants. The question is, what made...